RFA-Announcement of a Limited Competition for the Continuation of the Nuclear Receptor Signaling Atlas (U19)

The summary for the RFA-Announcement of a Limited Competition for the Continuation of the Nuclear Receptor Signaling Atlas (U19) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

RFA-Announcement of a Limited Competition for the Continuation of the Nuclear Receptor Signaling Atlas (U19): The National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, the National Heart, Lung and Blood Institute, the National Institute of Environmental Health Sciences, and the National Institute of Child Health and Human Development invite a competing continuation application to participate in a trans-NIH consortium to complete the development and implementation of an Atlas of Nuclear Hormone Receptors. The main objective will be to accrue, develop, analyze, and communicate information on the role(s) of Nuclear Hormone Receptors (NHR) in health and disease and to design studies with immediate translational impact on human disease, to catalyze the translation of basic knowledge into approaches that will help to understand and treat disease. The NIDDK and co-sponsoring NIH partners will commit $2.85M Total Costs to fund one award for up to five years.